CO HB1344

Exempts FDA-approved MDMA prescription drugs from Colorado's Schedule I controlled substance classification when placed on a different federal schedule or exempted from the Controlled Substances Act.

Allows behavioral health professionals in Colorado to prescribe and dispense MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD) and related comorbidities once federal approval is granted.

Requires that any FDA-approved MDMA drug product be controlled in Colorado according to the same federal control designation and be dispensed only by registered pharmacies to authorized individuals.

Establishes that current violations of Part 4 of Article 18 (drug possession prohibitions) remain enforceable and are not exempted by this bill.

Takes effect 12:01 a.m. the day after the 90-day period following final adjournment, unless subject to a referendum petition requiring voter approval at the November 2022 general election.